Yiqun Du, Jiong Wu, Changlu Hu, Wenyan Chen, Min Yan, Wei Li, Yongsheng Li, Yuee Teng, Huiping Li, Tao Huang, Yongkui Lu, Don X. Zhang, Jirong Peng, Feng Gao, Tingting Wang, Wenxuan Zhang, Jian Zhang. "A phase I/IIa study to evaluate the tolerability, safety, pharmacokinetics and efficacy of eciruciclib (BPI-1178) alone in advanced solid tumors and in combination with endocrine therapy for advanced or recurrent HR+/HER2- breast cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1064